New Document top_band
 
Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Read more on:    Url | Takeda | Sun Pharma
Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

 

Market News

Today's picks

Nifty, Bank Nifty, Wipro, Cairn & Hind Unilever

CSE to fund stake buyout in clearing corp by selling land

CSE needs to either tie-up with a clearing corporation or pick up a stake in it clearing corporation to meet the norms for regional stock ...

Sebi bars Sunplant, its directors from mobilising funds

Market regulator said the company raised a little over Rs 24 crore from over 3,200 investors through redeemable preference shares

Foreign investors allowed to take fresh positions in IRF

Exchanges allowed foreign investors to take further long positions in IRF

Sebi tweaks investment cap for FPIs in G-Secs

Sub-limit for longer time FPIs has been reduced by $5 billion as there was less demand in this category

Back to Top